Evolent Health Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Evolent Health, Inc. income statement - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue2.551.961.350.910.920.850.63
Cost of Revenue2.191.501.040.660.700.510.33
Gross Profit0.370.460.320.250.230.330.30
Operating Expenses
Research & Development0.000.000.000.020.020.000.00
Selling, General & Administrative0.260.360.270.210.210.390.31
Operating Expenses0.410.480.340.271.190.450.35
Operating Income-0.04-0.020.00-0.02-0.27-0.12-0.05
Other Income/Expense
Interest Income0.010.010.000.000.000.000.00
Interest Expense0.020.05-0.02-0.03-0.030.010.01
Other Income/Expense-0.02-0.13-0.030.000.05-0.200.00
Income
Income Before Tax-0.06-0.20-0.06-0.03-0.33-0.33-0.05
Income Tax Expense0.00-0.09-0.040.000.00-0.020.00
Net Income-0.06-0.11-0.02-0.04-0.33-0.30-0.05
Net Income - Continuous Operations-0.06-0.11-0.02-0.030.000.000.00
Net Income - Discontinued Operations0.000.000.00-0.010.000.000.00
EBITDA0.08-0.020.020.02-0.24-0.250.00
EBIT-0.06-0.15-0.05-0.02-0.30-0.31-0.05
Depreciation & Amortization0.120.120.070.030.060.060.04
Earnings Per Share
Basic EPS-1.00-1.00---4.00-4.00-1.00
Diluted EPS-1.00-1.00---4.00-4.00-1.00
Basic Shares Outstanding0.110.110.090.090.080.080.08
Diluted Shares Outstanding0.110.110.090.090.080.080.08